Medtronic completes MiniMed separation. Medtronic stock yields 3.00 percent

Published on 10/19/2026 at 10:28 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

MiniMed's separation closed on October 15, 2026. Medtronic stock costs EUR 84.47 on October 19, 2026 and pays USD 0.72 per share.

Separation and earnings context

Medtronic completed the MiniMed separation on October 15, 2026.
First-quarter fiscal 2027 revenue reached USD 9.76 billion, up 13.70 percent year over year.
Medtronic stock trades at EUR 84.47 at 10:19 a.m. CEST at Lang & Schwarz on October 19, 2026.
Wells Fargo raised its target from USD 102.00 to USD 104.00 on September 2, 2026.

Architekturrender eines modernen Glas-Bürogebäudes mit Teich und Landschaftsgestaltung — Medtronic plc (ISIN IE00BTN1Y115) Architektur-Render eines modernen Glas-Hauptsitzes mit Teich und Grünanlage, Illustration mit AI erstellt.

Medtronic plc (ISIN IE00BTN1Y115) was trading at EUR 84.47 at Lang & Schwarz on October 19, 2026 at 10:19 a.m. CEST. According to Medtronic on October 15, 2026, the company completed the separation of MiniMed Group, making the diabetes technology business fully independent.

Three milestones reshape the portfolio

The official release archive records three dated milestones: first-quarter fiscal 2027 revenue of USD 9.76 billion on September 1, 2026, a final MiniMed exchange ratio of 4.5939 on October 7, 2026, and completion of the separation on October 15, 2026, according to Medtronic.

The latest earnings provide the financial counterweight. In the first quarter of fiscal 2027, revenue rose 13.70 percent year over year to USD 9.76 billion, while adjusted earnings per share reached USD 1.45 against a USD 1.39 consensus estimate, as reported by MarketBeat on October 18, 2026.

What does the separation mean?

Medtronic's fiscal 2027 outlook calls for organic revenue growth of 7.25 percent to 7.75 percent and adjusted earnings per share of USD 5.94 to USD 6.00. The figures frame the separation as a portfolio change alongside a still-expanding operating outlook.

Analyst views remain mixed in detail but positive in direction. Wells Fargo raised its Medtronic target from USD 102.00 to USD 104.00 on September 2, 2026, while TD Cowen reaffirmed a buy rating with a USD 110.00 target on September 30, 2026, according to MarketBeat.

Key dates and valuation signals

Medtronic paid a quarterly dividend of USD 0.72 per share on October 16, 2026, following a September 25, 2026 record date. The company also carries a reported market capitalization of USD 121.3 billion and a 52-week range of USD 73.31 to USD 106.33, both cited by MarketBeat.

Portfolio focus meets execution

The MiniMed separation removes a major business from Medtronic's direct portfolio while the first-quarter figures show broad operating momentum. The next investor test is whether the remaining franchises can sustain the 7.25 percent to 7.75 percent organic growth outlook.

Medtronic stock was trading at EUR 84.47 at Lang & Schwarz on October 19, 2026 at 10:19 a.m. CEST. The further course of trading is shown by the continuously updated real-time quote of Medtronic stock.